Syneos Health Expands AI Partnerships to Scale Biopharma Commercial Operations
Syneos Health expanded partnerships with causaLens, KAI Conversations, and Sageforce to embed AI agents and causal AI into commercial biopharma workflows.
Latest AI Lifesciences news, analysis and insights from AIM Media House
Syneos Health expanded partnerships with causaLens, KAI Conversations, and Sageforce to embed AI agents and causal AI into commercial biopharma workflows.
The three-year agreement gives AstraZeneca access to Owkin’s K Pro platform and custom AI agents for clinical and competitive analysis.
GE HealthCare introduced new AI-powered MRI systems, workflow software, and neuroscience research tools at ISMRM 2026 to accelerate clinical imaging and MR research.
The New Jersey Hospital Association and Jade Global will provide hospitals with AI-powered operational tools targeting prior authorization, claims denials, interoperability, and reporting workflows.
Novo Nordisk transferred a clinical-stage Parkinson’s cell therapy program to Cellular Intelligence, which plans to use AI to optimize development and manufacturing.
Quanterix brand Lucent Diagnostics is integrating its Alzheimer’s blood biomarker test into Tempus Next to help neurologists identify eligible patients earlier.
IKS Health and Holyoke Medical Center signed a multi-year partnership focused on reducing administrative burden, improving workflows, and supporting financial sustainability through AI-driven and h...
FDA launched Elsa 4.0 and consolidated more than 40 internal systems into HALO as it expands AI-driven regulatory workflows.
The company is advancing dozens of clinical programs while integrating acquisitions and reducing operational expenses.
RTI International invested in Navidence to standardize disease and treatment definitions in AI-driven real-world evidence research across healthcare and life sciences.
Hartford HealthCare is deploying Cadence’s AI-supported monitoring to extend chronic care into patients’ homes, aiming to accelerate interventions and reduce hospitalizations.
Wellstar integrates AI-powered dispensing and infusion systems to improve medication safety, inventory visibility, and clinical workflows.
The New York-based provider rolls out a unified radiology system aimed at faster reporting, streamlined scheduling, and improved diagnostic workflows.
Oura is rolling out Hormonal Birth Control support and Menopause Insights to its global Ring members on May 6 — backed by a proprietary AI model, a clinically-validated questionnaire, and a same-da...
"We are boldly advancing a modern approach whereby FDA scientists can view safety signals and endpoints in real time as a trial progresses."
Vir Biotechnology is using AI-driven discovery and protein engineering to expand its oncology pipeline, with a recent Astellas deal reinforcing its platform strategy.
Abbott secured FDA clearance and CE Mark for its Ultreon 3.0 AI-powered OCT platform, designed to guide coronary interventions with real-time imaging insights.
The company says its CeeCee system will handle 25% of calls and automate up to 80% of intake documents by 2026.
Ochsner Health joins a $15 million American Heart Association network to use AI in scaling echocardiography screening for early detection of rheumatic heart disease.
Prezent introduced Prezent Vivo, combining AI and domain experts to deliver compliant life sciences communications across the full product lifecycle.